Clinical and biological characteristics of DHTR

• Why a seminar on DHTR? (France PIRENNE, France) - Voir l'intervention de France Pirenne
• Clinical presentation of DHTR and hyperhemolysis (Ross FASANO, USA) - Voir l'intervention de Ross Fasano
• DHTR in the French Hemovigilance system (Claire RIEUX, France) - Voir l'intervention de Claire Rieux
• Diagnosis of DHTR (Armand MEKONTSO DESSAP, France)
• Immuno-hematological findings in DHTR (Vincent THONIER) - Voir l'intervention de Vincent Thonier
• Treatment of DHTR (Pablo BARTOLUCCI, France)
• Prevention of DHTR (France PIRENNE, France)
• Case reports (Anoosha HABIBI, Slimane ALLALI FRANCE, Satheesh CHONAT, Ross FASANO USA) - Voir les interventions d'Anoosha Habibi , de Slimane Allali , et de Ross Fasano

Pathophysiology of DHTR: different pieces of a puzzle

• Allo-immunization and DHTR (Jeanne HENDRICKSON, USA) - Voir l'intervention de Jeanne Hendrickson
• Prevention of allo immunization: old drugs, new drugs? (Matthieu MAHEVAS, France)
• Hemolysis and immune activation in SCD (Karina YAZDANBAKHSH, USA) - Voir l'intervention de Karina Yazdanbakhsh
• Consequences of hemolysis (Eldad HOD, USA) - Voir l'intervention d'Eldad Hod
• Measurement and impact of hyperhemolysis in SCD (Pablo BARTOLUCCI, France)
• Mechanisms of red blood cell hemolysis (Sean STOWELL, USA)
• Complement in intravascular hemolysis and SCD (Lubka ROUMENINA, France)
• Spleen and red blood cell clearance (Pierre BUFFET)